Medical Doctor Program year 2025 Reported 2019–2025 Source: CMS Open Payments, 2026 publication

Eric Wieser

Orthopaedic Surgery of the Spine Arlington, TX Medical Doctor

NPI 1497740518 CMS profile 157960

800 Orthopedic Way, Arlington, TX 76015

Open in the dashboard

General payments

$1,471,309

133 records reported · program years 2019–2025

Research payments

$0

Paid to them · None reported · program years 2019–2025

Ownership & investment interest

$0

None reported

Through program year 2025, Eric Wieser of Arlington, TX is reported in the CMS Open Payments database as having received $1,471,309 across 133 general payments and $0 in research payments paid to them.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them.

General payments for this record sit in the 96th percentile of Orthopaedic Surgery of the Spine profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

7 rows
Year Kind Relative to this record's peak year Amount Records
2025 General $132,288 16
2024 General $139,238 25
2023 General $129,118 18
2022 General $259,793 19
2021 General $192,582 23
2020 General $227,248 19
2019 General $391,042 13

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • Eric Wieser
  • Orthopaedic Surgery of the Spine median
  • Middle half of Orthopaedic Surgery of the Spine
  • National median

In program year 2025, general payments to Eric Wieser were reported at $132,288. Among 1,704 Orthopaedic Surgery of the Spine profiles paid that year, the median was $2,061 and the middle half received between $347 and $14,651.

Show as a table
Year Eric Wieser Orthopaedic Surgery of the Spine median Middle half National median
2019 $391,042 $2,106 $337–$18,608 $163
2020 $227,248 $1,213 $156–$15,082 $114
2021 $192,582 $1,834 $271–$15,617 $132
2022 $259,793 $2,015 $320–$17,036 $149
2023 $129,118 $1,925 $336–$14,599 $160
2024 $139,238 $2,110 $341–$12,483 $164
2025 $132,288 $2,061 $347–$14,651 $169

Breakdown

Who paid General payments · program years 2019–2025
  1. Seaspine Orthopedics Corporation $661,141 32 payments
  2. Innovasis Inc $497,706 54 payments
  3. Orthofix Medical, Inc. $268,138 32 payments
  4. Biogennix, LLC $43,255 5 payments
  5. Globus Medical, Inc. $950 6 payments
  6. Centinel Spine, LLC $48 1 payment
  7. Medtronic, Inc. $33 1 payment
  8. Alphatec Spine, Inc $23 1 payment
  9. CPM Medical Consultants, LLC $15 1 payment

Every payment, record by record

What the payments were for General payments · program years 2019–2025
  1. Royalty or License $1,444,446 96 payments
  2. Travel and Lodging $22,959 20 payments
  3. Consulting Fee $3,000 1 payment
  4. Food and Beverage $904 16 payments
Products named General payments · program years 2019–2025
  1. Malibu Spine Hardware Systems $192,583 8 payments
  2. TXHA $147,369 12 payments
  3. Malibu Spine Hardware Systems $147,131 4 payments
  4. NewPort Spine Hardware Systems $131,807 12 payments
  5. ORYX $127,808 14 payments
  6. NewPort Spine Hardware Systems $121,113 8 payments
  7. Malibu Spine Hardware Systems $98,167 4 payments
  8. Physio-Stim $95,728 8 payments
  9. Malibu Orthopedic $95,491 12 payments
  10. ORYX Spine $62,455 8 payments
  11. Other $147,396 32 payments

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Prescribing to Medicare patients

Part D · data year 2024 · 17 drugs

Part D claims

2,444

Median for Orthopedic Surgery: 203

Drug cost

$18,760

Median for Orthopedic Surgery: $1,433

Branded share of claims

5.7%

Median for Orthopedic Surgery: 11.6%

Drugs this doctor was counted under in Medicare Part D 2024, by drug cost
Drug Type Relative to their largest Claims Drug cost
Methocarbamol Generic 423 $4,659
Celecoxib Generic 359 $3,863
Meloxicam Generic 959 $2,321
Gabapentin Generic 155 $2,045
Pregabalin Generic 33 $1,462
Hydrocodone-Acetaminophen Hydrocodone/Acetaminophen Brand 80 $1,096
Tramadol Hcl Generic 114 $782
Acetaminophen-Codeine Acetaminophen With Codeine Brand 59 $684
Methylprednisolone Generic 62 $537
Cyclobenzaprine Hcl Generic 46 $526

The 10 drugs with the highest cost, of 17 counted.

Drug cost is what was paid for the drugs at the pharmacy — by Medicare, the patient and others — and is not money to the prescriber. Medicare Part D only: drugs dispensed to Medicare beneficiaries. A drug with fewer than 11 claims for this prescriber is not published, so a missing drug does not mean zero. The medians are for the 18,934 Part D prescribers listed as Orthopedic Surgery; they describe a distribution and say nothing about conduct.

Billing to Medicare

Part B · data year 2024 · 53 billing codes

Paid by Medicare

$202,078

Medicare's payments for the services billed

Medicare patients

414

Average age 74

Services billed

1,535

225 women, 189 men among their patients

Share of this provider's Medicare patients with each condition
Condition among their Medicare patients Relative to the most common Share of patients
High blood pressure 75%
Arthritis 75%
Diabetes 35%
Depression 29%
Ischemic heart disease 26%
Chronic kidney disease 24%
Osteoporosis 18%
Atrial fibrillation 16%

Medicare Part B only: services billed to Medicare. Rows covering fewer than 11 beneficiaries are not published. Only drugs given in the clinic are itemised here; the rest of what this provider billed is in the total above.

Records

133 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Other Orthopaedic Surgery of the Spine in Texas

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2025

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record